Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.
about
Melanized fungi in human diseaseInfections caused by Scedosporium spp.Posaconazole: clinical pharmacology and potential for management of fungal infections.Therapy of infections caused by dematiaceous fungi.Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.Posaconazole: a new broad-spectrum antifungal agent.Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases.Scedosporium prolificans: an emerging pathogen in France?Posaconazole: when and how? The clinician's view.Immunomodulatory properties of antifungal agents on phagocytic cells.Immunotherapy against invasive mold infections.Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1→3)-β-D-glucan.Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.Recent Advances in the Treatment of Scedosporiosis and Fusariosis.
P2860
Q24633163-0DE48605-0532-4D91-8DB6-0C18AE03B793Q24657691-63507827-4FF6-4923-AD6E-2FD4C9A43E4FQ36233491-FBC9DB0C-9DB8-4D52-ACBE-8C3B061539D2Q36233517-5C7F6106-9C42-4072-83FA-D7A37CD66560Q36589297-2D9BA696-06DF-4177-9DF8-805224FD5CB2Q36828159-70F9F212-2BBA-435F-B797-50B653D6671BQ37334205-20AE90A8-B9FE-4A45-9946-1BAD2ED158A6Q37351705-439E45F2-DD50-496D-933D-16C51064D70CQ37901534-DE2C38E6-BC5A-4B74-B719-9539ADFB2813Q37943851-974C53EC-A24F-40FE-8B46-C2DB71AA27A3Q37965757-2902F415-5157-4D25-A5D2-5AE262F5BEEFQ39006744-5CC30F34-2782-4BE3-AC2D-98DA469B11B8Q41850557-A9B8C629-5C17-4F45-BFF8-0499563AFF55Q42095363-6D29FC06-004E-4CAF-BBA4-E3F2D43D5DA4Q55453637-72591160-36DB-41F3-8A3C-6DA93930E407
P2860
Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifungal activities of posac ...... e to Scedosporium prolificans.
@en
Antifungal activities of posac ...... e to Scedosporium prolificans.
@nl
type
label
Antifungal activities of posac ...... e to Scedosporium prolificans.
@en
Antifungal activities of posac ...... e to Scedosporium prolificans.
@nl
prefLabel
Antifungal activities of posac ...... e to Scedosporium prolificans.
@en
Antifungal activities of posac ...... e to Scedosporium prolificans.
@nl
P2093
P2860
P1476
Antifungal activities of posac ...... e to Scedosporium prolificans.
@en
P2093
A Maloukou
C Gil-Lamaignere
D Loebenberg
E Roilides
L Kourounaki
M Simitsopoulou
N Avramidis
P2860
P304
P356
10.1128/AAC.48.10.3801-3805.2004
P407
P577
2004-10-01T00:00:00Z